I am/have/had
I am looking for
Advanced Filters
Found 41 clinical trials
Korean Post-marketing Surveillance for Xeljanz XR (XRPMS)
Xeljanz(tofacitinib) is a potent, oral janus kinase inhibitor. Xeljanz Tab 5mg was approved by MFDS in 2014 for the treatment of adult patients with moderately to severely active rheumatoid
- 0 views
- 08 Apr, 2023
- 1 location